Cargando…
The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664512/ https://www.ncbi.nlm.nih.gov/pubmed/37990152 http://dx.doi.org/10.1186/s12874-023-02074-5 |
| _version_ | 1785148748464128000 |
|---|---|
| author | Lyden, Patrick Broderick, Joseph Grotta, James Kwiatkowski, Thomas Levine, Steven Frankel, Michael Haley, E. Clarke Tilley, Barbara |
| author_facet | Lyden, Patrick Broderick, Joseph Grotta, James Kwiatkowski, Thomas Levine, Steven Frankel, Michael Haley, E. Clarke Tilley, Barbara |
| author_sort | Lyden, Patrick |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10664512 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106645122023-11-21 The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17 Lyden, Patrick Broderick, Joseph Grotta, James Kwiatkowski, Thomas Levine, Steven Frankel, Michael Haley, E. Clarke Tilley, Barbara BMC Med Res Methodol Matters Arising BioMed Central 2023-11-21 /pmc/articles/PMC10664512/ /pubmed/37990152 http://dx.doi.org/10.1186/s12874-023-02074-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Matters Arising Lyden, Patrick Broderick, Joseph Grotta, James Kwiatkowski, Thomas Levine, Steven Frankel, Michael Haley, E. Clarke Tilley, Barbara The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17 |
| title | The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17 |
| title_full | The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17 |
| title_fullStr | The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17 |
| title_full_unstemmed | The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17 |
| title_short | The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17 |
| title_sort | difference between concealment and blinding in clinical trials and why both are important. a reply to garg and mickenautsch, bmc medical research methodology (2022) 22:17 |
| topic | Matters Arising |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664512/ https://www.ncbi.nlm.nih.gov/pubmed/37990152 http://dx.doi.org/10.1186/s12874-023-02074-5 |
| work_keys_str_mv | AT lydenpatrick thedifferencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT broderickjoseph thedifferencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT grottajames thedifferencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT kwiatkowskithomas thedifferencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT levinesteven thedifferencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT frankelmichael thedifferencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT haleyeclarke thedifferencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT tilleybarbara thedifferencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT lydenpatrick differencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT broderickjoseph differencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT grottajames differencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT kwiatkowskithomas differencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT levinesteven differencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT frankelmichael differencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT haleyeclarke differencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 AT tilleybarbara differencebetweenconcealmentandblindinginclinicaltrialsandwhybothareimportantareplytogargandmickenautschbmcmedicalresearchmethodology20222217 |